Washington [US], May 27 (ANI): According to the scientists at the University of Michigan Rogel Cancer Center, a small molecule has been identified that blocks a key pathway in brain tumours. But there was a problem: How to get the inhibitor through the bloodstream and into the brain to reach the tumour.